Soluble recombinant endostatin purified from Escherichia coli: Antiangiogenic activity and antitumor effect

Cancer Research

Volumn 61, Issue 2, 2001, Pages 478-481

  Huang, Xiaojun ^a   Wong, Michael K K ^b   Zhao, Qun ^a   Zhu, Zhenyu ^a   Wang, Kent Z Q ^a   Huang, Nancy ^a   Ye, Caisheng ^a   Gorelik, Elieser ^a   Li, Mengfeng ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOSTATIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG COST; DRUG POTENCY; DRUG PURIFICATION; ESCHERICHIA COLI; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; YEAST;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; COLLAGEN; ENDOSTATINS; ENDOTHELIUM, VASCULAR; ESCHERICHIA COLI; GENE EXPRESSION; HUMANS; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; SOLUBILITY; TUMOR CELLS, CULTURED;

EID: 0035863320     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis
2. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
3. Endostatin: Yeast production, mutants, and antitumor effect in renal cell carcinoma
4. Angiostatin and endostatin. Endothelial cell-specific endogenous inhibitors of angiogenesis and tumor growth
5. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
6. Use of T7 RNA polymerase to direct expression of cloned genes
7. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes
8. Cloning and expression of the gene for bacteriophage T7 RNA polymerase
9. Correct disulfide pairing and efficient refolding of detergent-solubilized single-chain Fv proteins from bacterial inclusion bodies
10. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor
11. Inactivation of human fibroblast growth factor-1 (FGF-1) activity by interaction with copper ions involves FGF-1 dimer formation induced by copper-catalyzed oxidation
12. Zinc ligand-disrupted recombinant human endostatin: Potent inhibition of tumor growth, safety and pharmacokinetic profile
13. Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N′-nitronitrosoguanidine
14. Immunology of spontaneous mammary carcinomas in mice. V. Acquired tumor resistance and enhancement in strain A mice infected with mammary tumor virus
15. Controlling basal expression in an inducible T7 expression system by blocking the target T7 promoter with lac repressor